These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8334938)

  • 41. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
    Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
    Kolb GF
    Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
    Slusser SO; Liberski SM; McGarrity TJ
    Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colorectal cancer screening: an overview of available methods and current recommendations.
    Early DS
    South Med J; 1999 Mar; 92(3):258-65. PubMed ID: 10094264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The feasibility of FOBT tests in colorectal cancer screening in Dobrogea.
    Suceveanu AI; Suceveanu A; Dumitru E; Alexandrescu L; Voinea F
    Rom J Gastroenterol; 2005 Sep; 14(3):213-7. PubMed ID: 16200229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Screening for colorectal cancer: what is the most effective strategy?].
    Merzenich H; Giersiepen K; Kieschke J; Zeeb H
    Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for colorectal cancer: the rationale and a recent advance in the detection of fecal occult blood.
    Friend WG
    Prog Clin Biol Res; 1985; 186():65-76. PubMed ID: 4034607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Colonic and rectal cancer screening using fecal occult blood analysis (our experience)].
    Trignano M; Uzzau A; Nonnis R; Terrosu G; Noce L; Farris A
    Chir Ital; 1986 Oct; 38(5):511-8. PubMed ID: 3815641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening hospital employees for colorectal cancer.
    Friedman CJ; Hunt EH; Wanebo HJ; Berry RE
    Va Med; 1983 Dec; 110(12):712-4. PubMed ID: 6666260
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comment the American Cancer Society recommendations. Early diagnosis of colorectal cancers: screening for patients at risk].
    Winkler R
    MMW Munch Med Wochenschr; 1981 May; 123(18):725-6. PubMed ID: 6785618
    [No Abstract]   [Full Text] [Related]  

  • 57. Subsite distribution of colorectal carcinoma and implications for screening; a retrospective audit of 1771 cases.
    Erkek B; Ozkan N; Bayar S; Genc V; Ekrem U; Kuzu A; Aribal D
    Hepatogastroenterology; 2007; 54(73):77-80. PubMed ID: 17419235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Screening for cancer--a current health service? An updating of screening for breast cancer, cervix cancer and colorectal cancer].
    Hoff G
    Tidsskr Nor Laegeforen; 1987 Aug; 107(23):1864-8. PubMed ID: 3660367
    [No Abstract]   [Full Text] [Related]  

  • 59. [Has polypectomy contributed to the prevention of colorectal cancer?].
    Ottenjann R; Burlefinger R
    Z Gastroenterol Verh; 1988 Apr; 23():57-61. PubMed ID: 2454569
    [No Abstract]   [Full Text] [Related]  

  • 60. [Colorectal cancer mortality can be reduced. Fecal blood screening is an efficient test].
    Kewenter J
    Lakartidningen; 1998 Jun; 95(25):2950-2. PubMed ID: 9674365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.